TP53 and melanoma: Previously, we showed that introduction of the p53 functional partner, p19Arf (p19Arf in mice, p14ARF in humans) into B16 melanoma cells restored the p53 pathway and promoted cell death in vitro and in vivo.8 However, the impact of apoptotic cell death may be limited and is not likely to actively promote an antitumor immune response.